paclitaxel has been researched along with Bright Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greka, A; Jeselsohn, R; Popovtzer, M; Rennke, HG; Siddiqui, B | 1 |
| Adjei, AA; Bekele, L; Vidal Vazquez, M | 1 |
2 other study(ies) available for paclitaxel and Bright Disease
| Article | Year |
|---|---|
Immune Complex-Mediated Proliferative Glomerulonephritis Induced by Paclitaxel Treatment.
Topics: Adult; Antigen-Antibody Complex; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Female; Glomerulonephritis; Humans; Immune Complex Diseases; Paclitaxel | 2016 |
Systemic chemotherapy in patients with renal failure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Glomerulonephritis; Humans; Kidney Failure, Chronic; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Urinary Bladder Neoplasms | 2001 |